In conclusion, within the gut-organ axis, TMAO is closely associated with the pathological changes of various chronic diseases by regulating processes such as apoptosis, pyroptosis, abnormal autophagy, and ferroptosis
It acts as a non-selective agonist at MC1R, MC3R, MC4R, and MC5R, with particularly high potency at MC1R, the receptor governing melanogenesis in epidermal melanocytes
Patients who previously relied on compounded medications because of cost concerns should know that pricing has become more competitive as more products have entered the market
High Adherence to GLP-1 Receptor Agonists: 18-Month Outcomes from the First Large Scale Operational Quality Follow-Up of the Yazen Model David Buchebner 1 , Elin Skoglund 2 , Kristofer Rigner 3 , Martin Carlsson 1,4 (PO4.146) 1-3
Track your food intake
Endocrinology 138, 839842